“Formulation Strategies and In Vitro Characterization of Talquetamab-Loaded Nanocarriers for Targeted Immunotherapy in Multiple Myeloma”, IJRDT, vol. 4, no. 1, pp. 41–61, Mar. 2026, doi: 10.62218/ijrdt.v4i1.166.